Workflow
Altimmune(ALT) - 2025 Q4 - Earnings Call Transcript
2026-03-05 14:32
Altimmune (NasdaqGM:ALT) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsAnnabel Samimy - Managing DirectorBoris Peaker - Managing DirectorChristophe Arbet-Engels - Chief Medical OfficerGreg Weaver - CFOJerry Durso - President and CEOLee Roth - PresidentLinda Richardson - Chief Commercial OfficerMichael DiFiore - Managing DirectorScot Roberts - Chief Scientific OfficerConference Call ParticipantsAndy Hsieh - Biotech Research AnalystRoger Song - Senior Equity Research AnalystWilliam Wood ...
Myers Industries(MYE) - 2025 Q4 - Earnings Call Transcript
2026-03-05 14:32
Myers Industries (NYSE:MYE) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsAaron Schapper - President and CEOBill Dezellem - Chief Investment OfficerMeghan Beringer - Senior Director of Investor RelationsSamantha Rutty - EVP and CFOConference Call ParticipantsChristian Zila - AnalystOperatorLadies and gentlemen, thank you for joining us, and welcome to the Myers 2025 fourth quarter and full year results call. After today's prepared remarks, we will host a question and answer session. I ...
Ciena(CIEN) - 2026 Q1 - Earnings Call Transcript
2026-03-05 14:32
Ciena (NYSE:CIEN) Q1 2026 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsAlyssa Shreves - VP and Equity ResearchAmit Daryanani - Senior Managing DirectorGary B. Smith - President and CEOGeorge Notter - Managing DirectorGregg Lampf - VP of Investor RelationsKarl Ackerman - Managing Director and Equity ResearchMarc Graff - Senior Vice President and CFOMeta Marshall - Managing DirectorScott McFeely - Executive AdvisorConference Call ParticipantsAdrienne Colby - Research AnalystJeff Koche - Associ ...
Amprius Technologies(AMPX) - 2025 Q4 - Earnings Call Transcript
2026-03-05 14:32
Amprius Technologies (NYSE:AMPX) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsAmit Dayal - Managing Director of Equity ResearchRicardo Rodriguez - CFOTom Stepien - CEOConference Call ParticipantsAustin Bohlig - Senior Equity Research AnalystChip Moore - Managing Director and Senior Research AnalystColin Rusch - Managing Director and Senior Research AnalystDerek Soderberg - Director and Senior Equity Research AnalystEric Stine - Senior Research Analyst of Clean Technology and Industri ...
CorMedix(CRMD) - 2025 Q4 - Earnings Call Transcript
2026-03-05 14:32
CorMedix (NasdaqGM:CRMD) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsBrandon Folkes - Managing DirectorDan Ferry - Managing DirectorJeevan Larson - Equity Research AssociateJoe Todisco - Chairman and CEOJohn Todaro - Managing DirectorLiz Hurlburt - EVP and COOSusan Blum - EVP and CFOConference Call ParticipantsRoanna Ruiz - Senior Managing Director and Senior Biotechnology AnalystOperatorGood morning, and welcome to the CorMedix fourth quarter and full year 2025 earnings and corpora ...
Lightwave Logic(LWLG) - 2025 Q4 - Earnings Call Transcript
2026-03-05 14:32
Lightwave Logic (NasdaqCM:LWLG) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsRyan Coleman - Investor RelationsYves LeMaitre - President and CEOOperatorWelcome to the Lightwave Logic Q4 and Full Year 2025 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad ...
Lexicon Pharmaceuticals(LXRX) - 2025 Q4 - Earnings Call Transcript
2026-03-05 14:32
Lexicon Pharmaceuticals (NasdaqGS:LXRX) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsCraig Granowitz - SVP and Chief Medical OfficerLisa DeFrancesco - SVP of Investor Relations and Corporate CommunicationsMike Exton - CEO and DirectorScott Coiante - SVP and CFOYigal Nochomovitz - DirectorConference Call ParticipantsJoseph Pantginis - Managing Director and Senior Healthcare AnalystNone - AnalystNone - AnalystNone - AnalystOperatorWelcome to the Lexicon Pharmaceuticals Fourth Quarter a ...
Myers Industries(MYE) - 2025 Q4 - Earnings Call Transcript
2026-03-05 14:32
Myers Industries (NYSE:MYE) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsAaron Schapper - President and CEOMeghan Beringer - Senior Director of Investor RelationsSamantha Rutty - EVP and CFOWilliam Dezellem - Chief Investment OfficerConference Call ParticipantsChristian Zila - AnalystOperatorLadies and gentlemen, thank you for joining us, and welcome to the Myers 2025 fourth quarter and full year results call. After today's prepared remarks, we will host a question and answer session ...
Adagio(IVVD) - 2025 Q4 - Earnings Call Transcript
2026-03-05 14:32
Invivyd (NasdaqGM:IVVD) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsBill Duke - CFOKatie Falzone - Senior VP of FinanceMarc Elia - Chairman of the Board of DirectorsRobert Allen - Chief Scientific OfficerTim Lee - Chief Commercial OfficerConference Call ParticipantsPatrick Trucchio - Biotechnology AnalystTom Schroeder - AnalystOperatorGood day. Thank you for standing by. Welcome to the Invivyd fourth quarter 2025 earnings conference call. At this time, all participants are on a list ...
MediWound(MDWD) - 2025 Q4 - Earnings Call Transcript
2026-03-05 14:32
MediWound (NasdaqGM:MDWD) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsBarry Wolfson - EVP of Strategy and Corporate DevelopmentGaia Shamis - Director of IR CommunicationsHani Luxenburg - CFOJosh Jennings - Managing DirectorOfer Gonen - CEOConference Call ParticipantsJason Kreyer - Senior Research AnalystJeff Jones - Managing Director and Senior AnalystMichael Okunewitch - Senior Research AnalystScott Henry - Managing Director and Senior Research AnalystSwayampakula Ramakanth - Manag ...